These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 8567417

  • 1. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
    Church MW, Kaltenbach JA, Blakley BW, Burgio DL.
    Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
    [Abstract] [Full Text] [Related]

  • 2. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
    Kaltenbach JA, Church MW, Blakley BW, McCaslin DL, Burgio DL.
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):493-500. PubMed ID: 9374173
    [Abstract] [Full Text] [Related]

  • 3. WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.
    Church MW, Blakley BW, Burgio DL, Gupta AK.
    J Assoc Res Otolaryngol; 2004 Sep; 5(3):227-37. PubMed ID: 15185124
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
    Schweitzer VG.
    Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin ototoxicity and otoprotection with sodium salicylate.
    Hyppolito MA, de Oliveira JA, Rossato M.
    Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):798-803. PubMed ID: 16758221
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system.
    Rybak LP, Ravi R, Somani SM.
    Fundam Appl Toxicol; 1995 Jul; 26(2):293-300. PubMed ID: 7589918
    [Abstract] [Full Text] [Related]

  • 7. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB, Chan DK, Roediger FC, Shaffer BR, Fraser JF, Musatov S, Selesnick SH, Kaplitt MG.
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [Abstract] [Full Text] [Related]

  • 8. Effect of protective agents against cisplatin ototoxicity.
    Rybak LP, Husain K, Morris C, Whitworth C, Somani S.
    Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
    [Abstract] [Full Text] [Related]

  • 9. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity.
    Olgun Y, Kırkım G, Kolatan E, Kıray M, Bagrıyanık A, Olgun A, Kızmazoglu DC, Ellıdokuz H, Serbetcıoglu B, Altun Z, Aktas S, Yılmaz O, Günerı EA.
    Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991
    [Abstract] [Full Text] [Related]

  • 10. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X, Whitworth CA, Rybak LP.
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [Abstract] [Full Text] [Related]

  • 11. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.
    Waissbluth S, Salehi P, He X, Daniel SJ.
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1597-605. PubMed ID: 22907029
    [Abstract] [Full Text] [Related]

  • 12. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].
    Liao YJ, Tang H.
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):266-9. PubMed ID: 14628479
    [No Abstract] [Full Text] [Related]

  • 13. [Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy].
    Hyppolito MA, de Oliveira AA, Lessa RM, Rossato M.
    Braz J Otorhinolaryngol; 2005 Jul; 71(3):268-73. PubMed ID: 16446928
    [Abstract] [Full Text] [Related]

  • 14. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
    Sun C, Wang X, Chen D, Lin X, Yu D, Wu H.
    Neurosci Lett; 2016 Apr 21; 619():142-8. PubMed ID: 26971701
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
    Kaur T, Borse V, Sheth S, Sheehan K, Ghosh S, Tupal S, Jajoo S, Mukherjea D, Rybak LP, Ramkumar V.
    J Neurosci; 2016 Apr 06; 36(14):3962-77. PubMed ID: 27053204
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of the protective effects of amifostine against cisplatin-induced toxicity.
    Hussain AE, Blakley BW, Nicolas M, Balderston J.
    J Otolaryngol; 2003 Oct 06; 32(5):294-7. PubMed ID: 14974858
    [Abstract] [Full Text] [Related]

  • 20. Experimental topical ototoxicity investigations: can we underestimate unilateral ototoxicity because of cross-hearing?
    Ikiz AO.
    Otolaryngol Head Neck Surg; 2000 May 06; 122(5):779-80. PubMed ID: 10793371
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.